✦ LIBER ✦

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

✍ Scribed by A. HILLARP; F. BAGHAEI; I. FAGERBERG BLIXTER; K. M. GUSTAFSSON; L. STIGENDAL; M. STEN-LINDER; K. STRANDBERG; T. L. LINDAHL

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of laboratory assays to measu

✍ Samama, M. M.; Martinoli, J.-L.; LeFlem, L.; Guinet, C.; Plu-Bureau, G.; Depasse 📂 Article 📅 2010 🏛 Schattauer 🌐 English ⚖ 643 KB

The discovery and development of rivarox

✍ Perzborn, Elisabeth; Roehrig, Susanne; Straub, Alexander; Kubitza, Dagmar; Misse 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 588 KB

Management consensus guidance for the us

✍ Turpie, A. G. G.; Kreutz, R.; Llau, J.; Norrving, B.; Haas, S. 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 382 KB

Effects of the Oral, Direct Factor Xa In

✍ Graff, Jochen; von Hentig, Nils; Misselwitz, Frank; Kubitza, Dagmar; Becka, Mich 📂 Article 📅 2007 🏛 Sage Publications 🌐 English ⚖ 360 KB

Effects of the oral, direct thrombin inh

✍ Lindahl, T.; Baghaei, F.; Fagerberg Blixter, I.; Gustafsson, K. M.; Stigendal, L 📂 Article 📅 2011 🏛 Schattauer 🌐 English ⚖ 343 KB

The mechanism of action of rivaroxaban –

✍ Meyer Michel Samama 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 354 KB